Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes

American Journal of Nephrology

Volumn 31, Issue 4, 2010, Pages 342-352

  Fujii, Hideki ^a   Kono, Keiji ^a   Nakai, Kentaro ^a   Goto, Shunsuke ^a   Komaba, Hirotaka ^a   Hamada, Yasuhiro ^a   Shinohara, Masami ^b   Kitazawa, Riko ^c   Kitazawa, Sohei ^c   Fukagawa, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CLEA Japan Inc   (Japan)

^c KOBE UNIVERSITY   (Japan)

Author keywords

Asymmetric dimethyl arginine; Diabetic nephropathy; Nitric oxide; Non obese type 2 diabetes mellitus; Oxidative stress; Spontaneously diabetic Torii rats

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULUS; MALE; MESANGIUM; NITROSATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77953970031     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000297290     Document Type: Article

References (42)

1. Komers R, Anderson S: Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 2003; 284:F1121-F1137.
2. Prabhakar SS: Role of nitric oxide in diabetic nephropathy. Semin Nephrol 2004; 24: 333-344.
3. Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB: Nitric oxide synthesis isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11: 71-79.
4. Hiragushi K, Sugimoto H, Shikata K, Yamashita T, Miyatake N, Shikata Y, Wada J, Kumagai I, Fukushima M, Makino H: Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and microalbuminuric patients with type 2 diabetes. Diabetes Res Clin Pract 2001; 53: 149-159.
5. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H: Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 1998; 41: 1426-1434.
6. Prabhakar S, Starnes J, Shi S, Lonis B, Tran R: Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 2007; 18: 2945-2952.
7. Li Z, Rodriguez-Iturbe B, Ni Z, Shahkarami A, Sepassi L, Vaziri ND: Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, Akt, guanylate cyclase, and calmodulin. Kidney Int 2005; 68: 2766-2772.
8. Erdely A, Freshour G, Maddox DA, Olson JL, Samsell L, Baylis C: Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production. Diabetologia 2004; 47: 1672-1676.
9. Koo JR, Vaziri ND: Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 2003; 63: 195-201.
10. Khamaisi M, Keynan S, Bursztyn M, Dahan R, Reinhartz E, Ovadia H, Raz I: Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes. Nephron Physiol 2006; 102: 72-80.
11. Masuyama T, Komeda K, Hara A, Noda M, Shinohara M, Oikawa T, Kanazawa Y, Taniguchi K: Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. Biochem Biophys Res Commun 2004; 314: 870-877. (Pubitemid 38112880)
12. Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H: Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 2005; 54: 2891-2903.
13. Onozato ML, Tojo A, Leiper J, Fujita T, Palm F, Wilcox CS: Expression of NG,NGdimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers. Diabetes 2008; 57: 172-180.
14. Koh EH, Kim MS, Park JY, Kim HS, Youn JY, Park HS, Youn JH, Lee KU: Peroxisome proliferator- activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes 2003; 52: 2331-2337.
15. Ahmad T, Ugarph-Morawski A, Li J, Bileviciute- Ljungar I, Finn A, Ostenson CG, Kreicbergs A: Bone and joint neuropathy in rats with type-2 diabetes. Regul Pept 2004; 15: 61-67.
16. Ahmad T, Ohlsson C, Saaf M, Ostenson CG, Kreicbergs A: Skeletal changes in type-2 diabetic Goto-Kakizaki rats. J Endocrinol 2003; 178: 111-116.
17. Ostenson CG, Fiere V, Ahmed M, Lindstrom P, Brismar K, Brismar T, Kreicbergs A: Decreased cortical bone thickness in spontaneously non-insulin-dependent diabetic GK rats. J Diabetes Complications 1997; 11: 319-322.
18. Shinohara M, Masuyama T, Shoda T, Takahashi T, Katsuda Y, Komeda K, Kuroki M, Kakehashi A, Kanazawa Y: A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 2000; 1: 89-100.
19. Kim DJ, Song KE, Park JW, Cho HK, Lee KW, Huh KB: Clinical characteristics of Korean type 2 diabetic patients in 2005. Diabetes Res Clin Pract 2007; 77(suppl 1):S252-S257.
20. Takeshita N, Ishida H, Yamamoto T, Koh G, Kurose T, Tsuji K, Okamoto Y, Ikeda H, Seino Y: Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein in rat models of non-insulindependent diabetes mellitus. Acta Endocrinol (Copenh) 1993; 128: 69-73.
21. Fujii H, Hamada Y, Fukagawa M: Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats. Bone 2008; 42: 372-379.
22. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M: Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. Kidney Int 2003; 63: 464-473.
23. Xia L, Wang H, Munk S, Kwan J, Goldberg HJ, Fantus IG, Whiteside CI: High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells. Am J Physiol Renal Physiol 2008; 295:F1705-F1714.
24. Chung SS, Ho EC, Lam KS, Chung SK: Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003; 14(suppl 3):S233-S236.
25. Hamada Y, Miyata S, Nii-Kono T, Kitazawa R, Kitazawa S, Higo S, Fukunaga M, Ueyama S, Nakamura H, Yodoi J, Fukagawa M, Kasuga M: Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol Dial Transplant 2007; 22: 1547-1557.
26. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, Yodoi J: Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 1999; 96: 4131-4136.
27. Hamada Y, Fujii H, Kitazawa R, Yodoi J, Kitazawa S, Fukagawa M: Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin- induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. Bone 2009; 44: 936-941.
28. Shioji K, Kishimoto C, Nakamura H, Masutani H, Yuan Z, Oka S, Yodoi J: Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 2002; 106: 1403-1409.
29. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO: Reactive oxygen species cause diabetes- induced decrease in renal oxygen tension. Diabetologia 2003; 46: 1153-1160.
30. Morcos M, Sayed AA, Bierhaus A, Yard B, Waldherr R, Merz W, Kloeting I, Schleicher E, Mentz S, Abd el Baki RF, Tritschler H, Kasper M, Schwenger V, Hamann A, Dugi KA, Schmidt AM, Stern D, Ziegler R, Haering HU, Andrassy M, van der Woude F, Nawroth PP: Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002; 51: 3532-3544.
31. Keynan S, Hirshberg B, Levin-Iaina N, Wexler ID, Dahan R, Reinhartz E, Ovadia H, Wollman Y, Chernihovskey T, Iaina A, Raz I: Renal nitric oxide production during the early phase of experimental diabetes mellitus. Kidney Int 2000; 58: 740-747.
32. Komers R, Allen TJ, Cooper ME: Role of endothelium- derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 1994; 43: 1190-1197.
33. Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE: Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant 2008; 23: 1346-1354.
34. Fard A, Tuck CH, Donis JA, Sciacca R, Di Tullio MR, Wu HD, Bryant TA, Chen NT, Torres-Tamayo M, Ramasamy R, Berglund L, Ginsberg HN, Homma S, Cannon PJ: Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 2000; 20: 2039-2044.
35. Ito A, Egashira K, Narishige T, Muramatsu K, Takeshita A: Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus. Circ J 2002; 66: 811-815.
36. Druhan LJ, Forbes SP, Pope AJ, Chen CA, Zweier JL, Cardounel AJ: Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry 2008; 47: 7256-7263.
37. Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, Cunnington C, Tousoulis D, Pillai R, Ratnatunga C, Stefanadis C, Channon KM: Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J 2009; 30: 1142-1150.
38. Satoh M, Fujimoto S, Arakawa S, Yada T, Namikoshi T, Haruna Y, Horike H, Sasaki T, Kashihara N: Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol Dial Transplant 2008; 23: 3806-3813.
39. Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S: Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy. Nephrol Dial Transplant 2009; 24: 1162-1169.
40. Chander PN, Gealekman O, Brodsky SV, Elitok S, Tojo A, Crabtree M, Gross SS, Goligorsky MS: Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004; 15: 2391-2403.
41. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, Pollock JS, Carmines PK: Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 2001; 12: 1630-1639.
42. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 2002; 61: 186-194.